RESOLVE | Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)
01-04-2024
-31-03-2029
Show more information
Organisation
ORTEC OPTIMIZATION TECHNOLOGY BV